Laser remains standard of DME therapy
Combination therapy also showing promise
The International Diabetes Federation estimates that in the European countries of Austria, France, Germany, Italy, Portugal and Spain there are 22.1 million people currently living with diabetes, and the Center for Disease Control and Prevention estimates that 25.8 million Americans also have the disease. As the global population continues to age, there is increasing pressure for treatments that are both clinically effective and economically efficient. Advances in laser treatment protocols allow it to meet both of these criteria, and combined therapies are showing promise as well.
The evolution of laser photocoagulation
The packet of photons in each micropulse contains much less energy than a whole pulse. When the train of micropulses reaches the target tissue, thermal elevation and its diffusion from the impact zone are limited significantly. The result is that the sublethal treatment affects only a small collection of retinal epithelial cells and just the tips of the photoreceptors, as opposed to the large crater created with standard continuous-wave laser therapies. In essence, the visible burn has been eliminated.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Evaluating the clinical performance of ZEISS AT ELANA and the new ’ELISA’* approach
August 4th 2025In this insightful analysis, Dr. Joong Hun Kim presents real-world clinical outcomes with bilateral implantation of ZEISS AT ELANA 841P. Dr. Kim recommends AT ELANA® 841P as an excellent option for patients undergoing cataract surgery as its fully trifocal optical design translates into a full range of vision. He also introduces the so-called ‘ELISA’ approach for patients requiring astigmatic correction in one eye only, combining AT ELANA 841P and ZEISS AT LISA tri toric 939MP. Early objective and subjective clinical data from this novel approach reveal promising visual outcomes and high patient satisfaction
